Metallomix is an innovative biopharmaceutical company building a pipeline of novel drugs based upon the use of cold isotopes facilitated by its proprietary isotope-selective modulation methods. The medicines we are developing are aimed to alleviate suffering, improve motor and cognitive functions, and enhance survival.